Main Article Content
Background: With the emergence of a SARS-CoV-2 infection pandemic in China and its spread to other countries, mortality was shown to be high and to a greater extent if there were underlying pathologies.
Methods: It is an ecological analytical (cases for Mexican states) and cross-sectional study (individual data), of the open records of confirmed and discarded cases for COVID-19 of the General Directorate of Epidemiology of the Ministry of Health of Mexico.
Results: A specific mortality of 10.99% is reported; being higher in men between with age 65 or higher. Mortality rates from underlying diseases were higher than those reported in the World Health Organization in United States of America and Brazil in August 2020. Asthma was found to be a protective factor for COVID-19 mortality.
Conclusion: It is concluded that mortality was higher in the presence of comorbidities.
Updated 7 May 2020
Yoo JH, Hong ST. The outbreak caseswith the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020;35(5):e62.
Carlos WG, Dela Cruz C, Cao B, Pasnick S, Jamil S, Novel Wuhan (2019-CoV) coronavirus. Am J Respi Crit Care Med. 2020; 201(4):7-8.
Zhang Y, Ku J, Li H, Cao B. A novel coronavirus (COVID-19) outbreak. A call for action. Chest. 2020;157(4):e99-e101.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.
Li Q, Guan X, Wu P, Wang X, Zohu L, Tong Y et al. Early transmisión dynamics in Wuhan, China, of novel coronavirus infected pneumonia. N Engl J Md; 2020.
Cited:27 March 2020.
Munster VJ, Koopmans M, van Doremalen, van Riel D, de Wit E. A novel coronavirus emerging in China- key questions for impact assessment. N Engl J Med 2020;382:692- 4.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727:37.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim Guidance; 2020.
Huang C, Wuang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Whuan, China. The Lancet. 2020;395(10223):497-506
Dirección General de Epidmeiología. Secretaría de Salud. Secretaría de Salud. Datos-Abiertos Bases históricas; 2020.
Padilla-Raygoza N, Sandoval-Salazar C, Diaz-Martínez DA, Navarro-Olivos E, Gallardo-Luna MJ, Magos-Vazquez FJ, et al. Evolution of COVID.19 infection in Mexico until March 23, 2020: A descriptive ecological study. Journal of Advances in Medicine and Medical Research. 2020;32(8):42-48.
Padilla-Raygoza Navarro-Olivos E, Gallardo-Luna MJ, Magos-Vázquez FJ. Evolution of COVID-19 infection in Mexico until 28 March, 2020: A descriptive ecological study. International Journal of Tropical Disease & Health. 2020;41(4):64-9.
Bulut C, Kato Y. Epidemiology of COVID-19 Turk J Med Sci. 2020;50 (S1-1):563-570.
Matrajt L, Leung T. Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of Coronavirus disease. Emerg. Infect. Dis. 2020;26(8).
Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, et al. Propagation analysis and prediction of the COVID-19. Infectious Disease Modelling. 2020;3:282-292.
World Health Organization. Coronavirus disease (COVID-19) dashboard; 2020.
Spagnolo PA, Manson JE, Joffe H. Sex and gender differences in health: What the COVID-19 pandemic can teach us. Annals of Internal Medicine; 2020.
Harapan H, Itoh N, Yufka A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health. 2020;13(2020):1-9.
Padilla-Raygoza N, Sandoval-Salazar C, Diaz-Becerril LA, Beltran-Campos V, Diaz-Martinez DA, Navarro-Olivos, et al. Update of the evoluction of SARS-CoV-2 infection, COVID_19, and mortality in Mexico until May 15, 2020: An ecological study. International Journal of Tropical Disease & Health. 2020;41(5):36-45.